CharlesErlichmanMD

Clinical Trials

• Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer Start of enrollment: 1999 Apr 01

  Completed

  Phase 1

• 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery Start of enrollment: 1999 Aug 01

  Completed

  Phase 1

• 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors Start of enrollment: 2002 Jan 01

  Completed

  Phase 1

• Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors Start of enrollment: 2002 Aug 01

  Completed

  Phase 1

• Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary Start of enrollment: 2004 Feb 01

  Completed

  Phase 2

• Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2004 Mar 01

  Completed

  Phase 2

• Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas Start of enrollment: 2004 Nov 01

  Terminated

  Phase 1

• CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors Start of enrollment: 2004 Oct 01

  Completed

  Phase 1

• Phase I Study of GW572016 With Topotecan to Treat Advanced Solid Malignancies Start of enrollment: 2004 Sep 01

  Completed

  Phase 1

• Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery Start of enrollment: 2008 Aug 01

  Completed

  Phase 1

• GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery Start of enrollment: 2009 Mar 31

  Active, not recruiting

  Phase 1

• Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer Start of enrollment: 2007 Nov 01

  Terminated

• Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer Start of enrollment: 2009 Sep 08

  Completed

  Phase 2

• Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery Start of enrollment: 2012 Mar 05

  Completed

  Phase 1

• Study of Safety and Tolerability of VLX600, an Iron Chelator, in Patients With Refractory Advanced Solid Tumors Start of enrollment: 2015 Feb 18

  Terminated

  Phase 1

• Join now to see all